Updated Jul 16, 2026
Jacques Rachelle Suzanne has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $54K.

Based on the SEC filing context (most recent filing dated 2026-05-21) the individual appears in relation to Corbus Pharmaceuticals Holdings, Inc. No widely available public biographical detail confirms a specific title, tenure, or background beyond this association. The name may reflect a multi-part given name or a non-U.S. naming convention; no evidence of death is found in the provided context. Additional sources would be needed to establish a confirmed current role, education, and career history.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | QURE | uniQure N.V. | S — Open-market sale | 2.0K | $27.06 | $54K |
| 2026-06-12 | QURE | uniQure N.V. | A — Grant or award | 7.5K | $0.00 | |
| 2026-05-21 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | A — Grant or award | 3.8K | $0.00 |
Based on the SEC filing context (most recent filing dated 2026-05-21) the individual appears in relation to Corbus Pharmaceuticals Holdings, Inc. No widely available public biographical detail confirms a specific title, tenure, or background beyond this association. The name may reflect a multi-part given name or a non-U.S. naming convention; no evidence of death is found in th…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($54K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jacques Rachelle Suzanne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.